November 8, 2018 / 10:48 PM / 4 days ago

BRIEF-Sandoz Issues Voluntary Nationwide Recall Of 1 Lot Of Losartan Potassium & Hydrochlorothiazide

Nov 8 (Reuters) - Novartis AG:

* SANDOZ INC. ISSUES VOLUNTARY NATIONWIDE RECALL OF ONE LOT OF LOSARTAN POTASSIUM AND HYDROCHLOROTHIAZIDE DUE TO THE DETECTION OF TRACE AMOUNTS OF NDEA (N-NITROSODIETHYLAMINE) IMPURITY FOUND IN THE ACTIVE PHARMACEUTICAL INGREDIENT (API)

* SANDOZ - NOT RECEIVED ANY REPORTS OF ADVERSE EVENTS RELATED TO LOT OF LOSARTAN POTASSIUM HYDROCHLOROTHIAZIDE TABLETS, USP 100MG/25MG BEING RECALLED Source text for Eikon: Further company coverage:

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below